NDC 70954-151
Naproxen Oral Suspension
Naproxen Oral
Naproxen Oral Suspension is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Novitium Pharma Llc. The primary component is Naproxen.
| Product ID | 70954-151_252726a7-757a-4b97-b5b8-ffff4ac1d103 |
| NDC | 70954-151 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Naproxen Oral Suspension |
| Generic Name | Naproxen Oral |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2021-03-12 |
| Marketing Category | ANDA / |
| Application Number | ANDA211910 |
| Labeler Name | Novitium Pharma LLC |
| Substance Name | NAPROXEN |
| Active Ingredient Strength | 125 mg/5mL |
| Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |